EUVIMEDEUVIMED entdecken
LeserbriefKohortenstudie

Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: A real-world propensity score-matched cohort study

María Paz Martínez-Vidal, Montse Robustillo Villarino, Elena Bernad-Asencio, Cristina Fernández-Carballido, Mauricio Mínguez Vega, Mabel Prina-López, Cintia Romera-López, Blanca Molina-Vidal, Antonio Álvarez de Cienfuegos

Osteoporosis International · 02.11.2026

DOI: 10.1007/s00198-026-08291-0 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Osteoporosis International, online erschienen am 02.11.2026. Verfasst von María Paz Martínez-Vidal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Vega Baja, Orihuela, Alicante, Spain. mpmavidal@yahoo.es. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Hospital Universitario Vega Baja, Orihuela, Alicante, Spain. mpmavidal@yahoo.es.
  • Hospital Universitari de la Plana, Vila-real, Spain.
  • Hospital Universitario Marina Baixa, Alicante, Spain.
  • Hospital Universitario Sant Joan d'Alacant, Alicante, Spain.
  • Hospital General Universitario Virgen de los Lirios, Alcoy, Alicante, Spain.
  • Hospital General Universitario de Elche, Alicante, Spain.

Zitieren

APA

Martínez-Vidal, M. P., Robustillo Villarino, M., Bernad-Asencio, E., Fernández-Carballido, C., Mínguez Vega, M., Prina-López, M., Romera-López, C., Molina-Vidal, B., & Álvarez de Cienfuegos, A. (2026). Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: A real-world propensity score-matched cohort study. Osteoporosis International. https://doi.org/10.1007/s00198-026-08291-0

Vancouver

Martínez-Vidal MP, Robustillo Villarino M, Bernad-Asencio E, Fernández-Carballido C, Mínguez Vega M, Prina-López M, et al. Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: A real-world propensity score-matched cohort study. Osteoporosis International. 2026. doi:10.1007/s00198-026-08291-0

BibTeX
@article{MartnezVidal2026,
  author = {Martínez-Vidal, María Paz and Robustillo Villarino, Montse and Bernad-Asencio, Elena and Fernández-Carballido, Cristina and Mínguez Vega, Mauricio and Prina-López, Mabel and Romera-López, Cintia and Molina-Vidal, Blanca and Álvarez de Cienfuegos, Antonio},
  title = {Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: A real-world propensity score-matched cohort study},
  journal = {Osteoporosis International},
  year = {2026},
  doi = {10.1007/s00198-026-08291-0}
}
Kostenlos starten →